[1]段绍杰,姚树坤,魏润杰,等.系统生物学——中西医结合的桥梁[J].中国中西医结合杂志, 2019, 39(12): 1418-1421.
[2]董月.系统生物学促进中医现代化[J].中国中医药现代远程教育, 2021, 19(4): 84-87.
[3]Li L, Wang Y, Liu S. Application of pseudotargeted method combined with multivariate statistical analysis for the quality assessment of traditional Chinese medicine preparation, Sanhuang Tablet as a case[J]. Anal Bioanal Chem, 2020, 412(23): 5863-5872.
[4]Zhang R, Zhu X, Bai H, et al. Network pharmacology databases for traditional Chinese medicine: review and assessment[J]. Front Pharmacol, 2019, 10: 123.
[5]霍梦琪, 彭莎, 任越, 等. 基于系统中药学的中药功效标志物发现与应用[J]. 中国中药杂志, 2020, 45(14): 3245-3250.
[6]王露露,李冰,王圳伊,等.基于“整体观”系统生物学技术在中药研究中的应用进展[J].中草药, 2020, 51(19): 5053-5064.
[7]Chen G, Xue WD, Zhu J. Full genetic analysis for genomewide association study of Fangji: a powerful approach for effectively dissecting the molecular architecture of personalized traditional Chinese medicine[J]. Acta Pharmacol Sin, 2018, 39(6): 906-911.
[8]Hodel F, Chong AY, Scepanovic P, et al. Human genomics of the humoral immune response against polyomaviruses[J]. Virus Evol, 2021, 7(2): veab058.
[9]Wang Y, Hu LF, Zhou TJ, et al. Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations[J]. Biomaterials, 2021, 277: 121108.
[10]Hu J, Qiu R, Li C,et al. Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review[J]. BMC Complement Med Ther, 2021, 21(1): 217.
[11]吴凡,李泽庚,董昌武,等. 肺系病证候学研究进展[J].江西中医药大学学报, 2021, 33(4): 113-115.
[12]李嘉丽. 脾气虚证胃癌前病变小鼠microRNA基因组学及黄芪甲苷干预机制研究[D]. 广州:广州中医药大学, 2021.
[13]Suo T, Wang H, Li Z. Application of proteomics in research on traditional Chinese medicine[J]. Expert Rev Proteomics, 2016, 13(9): 873-881.
[14]冯宇,周曼丽,王健章,等. 蛋白组学在中医心系病症证候的研究进展[J].世界中医药, 2020, 15(16): 2507-2510.
[15]Xiao Q, Zhang F, Xu L,et al. Highthroughput proteomics and AI for cancer biomarker discovery[J]. Adv Drug Deliv Rev, 2021, 176: 113844.
[16]郭玲建,祝利民. 基于蛋白组学的中医药辨治大肠癌的研究概述[J].世界科学技术中医药现代化, 2020, 22(8): 2922-2926.
[17]叶嘉豪,胡志希,杨梦,等. 冠心病不同证候的蛋白质组学研究进展[J].中医药导报, 2021, 27(1): 122-126.
[18]米杰,马宝良.四妙散在泌尿系统疾病中的临床应用[J].中国中西医结合肾病杂志, 2009, 10(12): 1094-1095.
[19]林彤,李丽,梁彩君,等.四妙散治疗肾病综合征、痛风及湿疹的系统生物学研究[J].中医药导报, 2020, 26(13): 124-128,175.
[20]Wang T, Liu J, Luo X, et al. Functional metabolomics innovates therapeutic discovery of traditional Chinese medicine derived functional compounds[J]. Pharmacol Ther, 2021, 224: 107824.
[21]Wang P, Wang Q, Yang B,et al. The progress of metabolomics study in traditional Chinese medicine research[J]. Am J Chin Med, 2015, 43(7): 1281-310.
[22]徐欣,张文华,罗夏琳,等.系统生物学驱动的小分子代谢组学策略创新驱动中药现代研究[J].世界科学技术中医药现代化, 2019, 21(3): 333-341.
[23]Qu T, Gao Y, Li A, et al. Systems biology analysis of the effect and mechanism of total flavonoids of Astragali Radix against cyclophosphamideinduced leucopenia in mice[J]. J Pharm Biomed Anal, 2021, 205: 114357.
[24]王荣荣,吕佳霖,贺明帅,等.苍耳子致小鼠肝损伤的1HNMR代谢组学分析[J].辽宁中医药大学学报, 2021, 23(10): 34-39.
[25]程建安,袁媛,俞圆,等.赶黄草总黄酮对酒精性脂肪肝小鼠肝保护作用的代谢组学研究[J].中国现代应用学, 2021, 38(24): 3160-3166.
[26]Guo N, Wang P, Yang J,et al. Serum metabolomic analysis of coronary heart disease patients with stable angina pectoris subtyped by traditional chinese medicine diagnostics reveals biomarkers relevant to personalized treatments[J]. Front Pharmacol, 2021, 12: 664320.
[27]牛芊,邢文龙,刘红旭,等.丹红注射液对不稳定型心绞痛患者围手术期代谢组学的影响[J].世界中医药, 2021,16(12): 1900-1908.
[28]王亮,李绍旦,王鹏,等.中医药干预失眠模型动物的代谢组学研究进展[J].中医药学报, 2021, 49(11): 91-95.
[29]赵琳儒,何盼,李杰,等.柴芩宁神颗粒改善失眠大鼠睡眠作用的海马代谢组学研究[J/OL].中国中药杂志,2021.doi: 10.19540/j.cnki.cjcmm.20211230.702.